Innocorp Limited (INNOCORP.BO)
INR 6.21
(-0.16%)
INR 6.21
(-0.16%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 2.23 Million | -13.41 Million | 662 Thousand | 2.91 Million | 309.89 Thousand | -3.66 Million |
| Net Income | -2.61 Million | 53.74 Million | -1.71 Million | 312.76 Thousand | -12.24 Million | -9.9 Million |
| Depreciation & Amortization | 477 Thousand | 1.2 Million | 1.87 Million | 1.77 Million | 2.75 Million | 4.18 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 12.36 Million | -5.91 Million | -606 Thousand | 1.03 Million | 4.23 Million | 1.32 Million |
| Other non-cash items | -8.06 Million | -62.45 Million | 1.1 Million | -209.42 Thousand | 5.56 Million | 731.64 Thousand |
| Investing Cash Flow | 33 Thousand | 72 Million | -956 Thousand | 148.76 Thousand | 12.55 Million | -1.13 Million |
| Investments in PPE | -4.23 Million | -61 Thousand | -1.01 Million | -2.01 Million | -2250.00 | -3 Million |
| Acquisitions | 4.27 Million | 72.06 Million | - | 2.15 Million | 12.55 Million | 1.8 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 4.27 Million | 72.06 Million | 57 Thousand | 3215.00 | 3395.00 | 74.63 Thousand |
| Financing Cash Flow | - | -58.58 Million | 188 Thousand | -3.04 Million | -12.76 Million | 4.79 Million |
| Debt repayment | - | -35.61 Million | -1.35 Million | -1.22 Million | -10.03 Million | -7 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | -22.96 Million | 1.54 Million | -1.81 Million | -2.73 Million | 11.8 Million |
| Accounts receivables | -344 Thousand | 1.15 Million | 1.08 Million | -2.51 Million | 1.84 Million | 619.18 Thousand |
| Accounts payables | 1.36 Million | 81 Thousand | -2.92 Million | 1.68 Million | -1.00 | - |
| Inventory | - | 259 Thousand | 227.00 | 531.00 | 2.64 Million | 773.76 Thousand |
| Other working capital | 11.33 Million | -7.4 Million | 1.24 Million | 1.87 Million | -261.6 Thousand | -67.29 Thousand |
| Cash at beginning of period | 70 Thousand | 67 Thousand | 173 Thousand | 146.65 Thousand | 54.28 Thousand | 52.87 Thousand |
| Cash at end of period | 2.33 Million | 71 Thousand | 67 Thousand | 173.25 Thousand | 146.65 Thousand | 54.28 Thousand |
| Capital Expenditure | -4.23 Million | -61 Thousand | -1.01 Million | -2.01 Million | -2250.00 | -3 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 2.26 Million | 4000.00 | -106 Thousand | 26.59 Thousand | 92.37 Thousand | 1413.00 |
| Free Cash Flow | -2 Million | -13.47 Million | -351 Thousand | 905.4 Thousand | 307.64 Thousand | -6.67 Million |
| Breakdown | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -359 Thousand | -2.61 Million | -240 Thousand | -981 Thousand | -1.04 Million | 53.74 Million |
| Depreciation & Amortization | - | 477 Thousand | 161 Thousand | 126 Thousand | 126 Thousand | 1.2 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | 12.36 Million | - | - | - | -5.91 Million |
| Other non-cash items | 359 Thousand | -8.06 Million | 240 Thousand | 981 Thousand | 1.04 Million | -62.45 Million |
| Investing Cash Flow | - | 33 Thousand | - | - | - | 72 Million |
| Investments in PPE | - | -4.23 Million | - | - | - | -61 Thousand |
| Acquisitions | - | 4.27 Million | - | - | - | 72.06 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | 4.27 Million | - | - | - | 72.06 Million |
| Financing Cash Flow | - | - | - | - | - | -58.58 Million |
| Debt repayment | - | - | - | - | - | -35.61 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | -22.96 Million |
| Accounts receivables | - | -344 Thousand | - | - | - | 1.15 Million |
| Accounts payables | - | 1.36 Million | - | - | - | 81 Thousand |
| Inventory | - | - | - | - | - | 259 Thousand |
| Other working capital | - | 11.33 Million | - | - | - | -7.4 Million |
| Cash at beginning of period | - | 70 Thousand | 84 Thousand | 1.06 Million | 70 Thousand | 67 Thousand |
| Cash at end of period | - | 2.33 Million | 406 Thousand | 84 Thousand | -1.04 Million | 71 Thousand |
| Capital Expenditure | - | -4.23 Million | - | - | - | -61 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | 2.26 Million | 322 Thousand | -981 Thousand | -1.11 Million | 4000.00 |
| Free Cash Flow | - | -2 Million | 322 Thousand | -981 Thousand | -1.04 Million | -13.47 Million |
PLLTL
SEMAC
JAGSNPHARM
EVG
BEIJF
300042